Even in cases where cancer cells can adapt to the loss of IDH1 over time, such as restoring IDH3 complex activity, they nevertheless remain significantly disadvantaged compared to tumours exhibiting wild‐type IDH1 for growth in vivo, further emphasizing the importance of IDH1 in PCa cells. This evidence concerns the gene IDH1 and posterior cortical atrophy.